arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

download Export Data

Relay Therapeutics, Inc.

RLAY

$16.98 ▼ -1.06 (-5.88%) at close

31 Visible periods

25 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Relay Therapeutics, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $3.4B

Dividend Yield —

Revenue Growth -48.3% ↗

Op. Margin None

ROIC -8.1% ↗

FCF / Share $-0.27 ↗

Trailing P/E —

Price / Book 4.2x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Nov 5, 2026.

31-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$350.00K

↓ -48.3% —

Net Income Profit after all expenses

$-73.29M

↑ +4.9% —

FCF / Share Free cash flow per share

$-0.27

↑ +6.1% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Revenue Growth YoY (%)	-48.3% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-704%)	-60.9% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-862%)	—	—	—	-23.3% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-391%)	100.0% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1150%)	N/M	N/M	4327.9% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+53998%)	N/M	7226.2% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+90227%)	-67.4% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-942%)	-46.1% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-676%)	-55.4% Weak → Weak Stable Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-792%)	-48.3% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-704%)	-56.8% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-809%)	-56.0% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-800%)	—	—	—	—	—	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	0.0% Caution ↓ Caution Declining Year-over-year change in earnings per share Optimal: > 10%	10.9% Fair ↓ Fair Declining Year-over-year change in earnings per share Optimal: > 10%	26.2% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	31.7% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	40.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	25.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	37.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-16.7% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	14.8% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	20.5% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	-21.8% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	28.9% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-14.1% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	—	11.3% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	-15.2% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	4.9% Caution ↓ Caution Declining Year-over-year change in net income	4.9% Caution ↓ Caution Declining Year-over-year change in net income	27.8% Excellent ↑ Excellent Improving Year-over-year change in net income	5.3% Fair ↓ Fair Declining Year-over-year change in net income	5.3% Fair ↓ Fair Declining Year-over-year change in net income	5.3% Fair ↓ Fair Declining Year-over-year change in net income	9.0% Fair ↓ Fair Declining Year-over-year change in net income	13.6% Fair ↑ Fair Improving Year-over-year change in net income	13.6% Fair ↑ Fair Improving Year-over-year change in net income	13.6% Fair ↑ Fair Improving Year-over-year change in net income	-23.7% Weak ↑ Weak Improving Year-over-year change in net income	-51.9% Weak ↓ Weak Declining Year-over-year change in net income	-51.9% Weak ↓ Weak Declining Year-over-year change in net income	-51.9% Weak ↓ Weak Declining Year-over-year change in net income	-0.1% Weak ↑ Weak Improving Year-over-year change in net income	-47.1% Weak → Weak Stable Year-over-year change in net income	-47.1% Weak ↑ Weak Improving Year-over-year change in net income	-47.1% Weak ↑ Weak Improving Year-over-year change in net income	N/M	-69.5% Weak → Weak Stable Year-over-year change in net income	-69.5% Weak → Weak Stable Year-over-year change in net income	-69.5% Weak ↑ Weak Improving Year-over-year change in net income	N/M	-75.5% Weak Weak Year-over-year change in net income	-75.5% Weak Weak Year-over-year change in net income	—	—	—	—	—	—
FCF Growth YoY (%)	—	34.6% Excellent Excellent Year-over-year change in free cash flow	—	32.9% Excellent Excellent Year-over-year change in free cash flow	—	-9.2% Weak Weak Year-over-year change in free cash flow	—	—	—	30.0% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	43.3% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	136.8% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	202.5% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	—	22.9% Excellent Excellent Compound annual revenue growth over 3 years	163.7% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	119.1% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	-16.1% Weak Weak Compound annual revenue growth over 5 years	25.8% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Operating Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	-291.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2046%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	-373.9% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3216%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.74x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.70x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.82x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.81x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	—	0.95x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.76x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.81x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.64x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	1.07x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	0.73x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.88x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	—	0.95x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.84x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.60x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	1.30x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	—	-1.09x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	-1.00x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.94x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.98x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.40x Good Good Free cash flow relative to reported net income Optimal: > 1x	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Return on Invested Capital (%)	-8.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-9.7% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-8.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-10.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.1% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-9.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-8.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-9.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-11.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.6% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-9.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-10.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-6.8% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-7.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-6.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-8.4% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-24.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-4.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	3.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-4.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	9.7% Fair ↓ Fair Declining Return earned on debt + equity capital invested Optimal: > 10%	10.3% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	11.3% Good → Good Stable Return earned on debt + equity capital invested Optimal: > 10%	10.9% Good Good Return earned on debt + equity capital invested Optimal: > 10%	11.2% Good Good Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	-9.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-11.2% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-9.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-12.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-10.5% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-10.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	-9.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-10.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-8.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-11.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-9.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	-7.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	-6.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-27.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-5.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	—	-4.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	-8.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—	—
Return on Common Equity (%) (%)	-8.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-155%)	-11.4% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-176%)	-9.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-165%)	-12.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-185%)	-11.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-177%)	-10.7% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-171%)	-9.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-165%)	-9.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-165%)	-11.9% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-180%)	-10.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-173%)	-11.1% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-174%)	-12.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-181%)	-11.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-178%)	-10.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-171%)	-7.1% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-147%)	-6.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-141%)	-8.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-153%)	-7.4% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-149%)	-7.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-150%)	-7.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-149%)	-6.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-145%)	-5.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-138%)	4.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-69%)	-3.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-123%)	11.0% Fair → Fair Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-26%)	12.3% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-18%)	13.3% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-12%)	9.0% Caution Caution Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-40%)	10.1% Fair Fair Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-32%)	—	—

⚖️ Is the balance sheet risky? 1 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Net Debt (USD)	$-121.19M	$-204.59M	$-84.02M	$-91.56M	$-113.94M	$-93.54M	$-124.29M	$-152.36M	$-134.12M	$-152.87M	—	$-151.33M	$-145.90M	$-161.28M	—	$-354.64M	$-107.74M	$-119.44M	—	$-228.56M	$-260.07M	$-262.72M	$-447.65M	$-559.28M	$-137.05M	$-70.34M	$-41.95M	$-29.05M	$-39.36M	—	—

📊 What does each share earn? 6 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Revenue per Share (USD)	$0.00	$0.02	—	$0.00	$0.00	$0.05	—	$0.00	$0.00	$0.08	—	$0.21	$0.00	$0.00	—	$0.00	$0.00	—	—	$0.01	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.41	$-0.41	$-0.31	$-0.43	$-0.41	$-0.46	$-0.42	$-0.63	$-0.69	$-0.62	$-0.67	$-0.54	$-0.81	$-0.78	$-0.55	$-0.76	$-0.71	—	$-0.62	$-0.66	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.27	$-0.28	—	$-0.36	—	$-0.43	—	$-0.54	$-0.50	$-0.40	—	—	—	$-0.57	—	—	$-0.54	—	—	$-0.59	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$4.07	$3.39	$3.26	$3.52	$3.88	$4.23	$4.64	$5.98	$5.13	$5.64	—	$6.32	$6.64	$7.27	—	$8.28	$7.18	$7.76	—	$6.16	$6.68	$8.10	—	$7.95	$-49.08	—	—	—	—	—	—
Tangible Book Value per Share (USD)	$4.07	$3.39	$3.26	$3.52	$3.88	$4.23	$4.64	$5.98	$5.13	$5.64	—	$6.32	$6.64	$7.27	—	$8.28	$7.18	$7.76	—	$6.16	$6.68	$8.10	—	$7.95	$-49.08	—	—	—	—	—	—
Basic Weighted Avg Shares (shares)	202.85M	179.85M	—	172.39M	171.26M	169.23M	—	140.23M	132.82M	130.84M	—	122.23M	121.68M	121.32M	—	110.91M	108.64M	—	—	92.69M	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Working Capital (USD)	$877.28M	$628.71M	$552.70M	$591.41M	$647.87M	$702.61M	$758.48M	—	—	$732.96M	—	$781.05M	$812.77M	$887.92M	—	$1.02B	—	$874.10M	—	—	$655.89M	$726.35M	—	$706.18M	$303.10M	—	—	—	—	—	—
Total Equity (USD)	$890.01M	$642.18M	$567.06M	$607.71M	$665.66M	$721.08M	$777.79M	$838.86M	$681.74M	$745.76M	$752.00M	$778.37M	$810.12M	$883.41M	$950.22M	$999.77M	$779.64M	$841.97M	$897.81M	$571.09M	$618.53M	$732.79M	$763.29M	$713.52M	$-225.39M	$-202.35M	$-180.44M	$-158.29M	$-140.02M	$-124.16M	$-110.93M

📋 What is driving earnings? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Sales/Revenue/Turnover (USD)	$350.00K	$3.00M	$7.00M	$0.00	$677.00K	$7.68M	$0.00	$0.00	$0.00	$10.01M	$-1.00K	$25.20M	$119.00K	$226.00K	$253.00K	$344.00K	$365.00K	$419.00K	$567.00K	$666.00K	$844.00K	$952.00K	—	—	—	—	—	—	—	—	—
Depreciation Expense (USD)	$360.00K	$504.00K	$599.00K	$748.00K	—	$1.21M	$1.33M	$1.37M	$1.37M	$1.40M	$1.38M	—	—	$1.20M	$1.17M	—	$956.00K	$975.00K	$1.03M	$1.01M	—	$919.00K	$912.00K	—	—	$859.00K	$853.00K	$634.00K	—	—	—
Net Income, GAAP (USD)	$-73.29M	$-73.29M	$-54.89M	$-77.06M	$-77.06M	$-77.06M	$-76.00M	$-81.39M	$-81.39M	$-81.39M	$-83.50M	$-94.24M	$-94.24M	$-94.24M	$-67.50M	$-62.05M	$-62.05M	$-62.05M	$-67.46M	$-42.18M	$-42.18M	$-42.18M	$35.28M	$-24.89M	$-24.89M	$-24.89M	$-23.91M	$-14.18M	$-14.18M	—	—
Operating Cash Flow (USD)	$-54.11M	$-51.11M	$-44.87M	$-62.12M	—	$-73.21M	$-57.87M	$-75.08M	$-65.83M	$-50.32M	$-89.19M	—	—	$-67.13M	$-57.08M	—	$-57.09M	$-49.17M	$-39.71M	$-53.20M	—	$46.64M	$-35.27M	—	—	$-22.33M	$-22.76M	$-17.50M	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 8 years · 31 quarters

Relay Therapeutics, Inc.

Analytical Summary

31-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare RLAY with peers